3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Peripheral Nervous System Diseases
3
Lymphoma
3
Lymphoma, Large B-Cell, Diffuse
2
Breast Neoplasms
2
Wilms Tumor
1
Vaso-Occlusive Crises
1
Sarcoma
1
Prostatic Neoplasms
1
Pain
1
Neurotoxicity Syndromes
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Extranodal NK-T-Cell
1
Leukemia
1
Kidney Neoplasms
1
Esophagitis
1
Dendritic Cell Sarcoma, Interdigitating
1
Burkitt Lymphoma
1
Anemia, Sickle Cell
1
Interventions
Doxorubicin
4
pazopanib
2
Ifosfamide
2
saracatinib
1
sapanisertib
1
indolepropanol phosphate
1
Watchful Waiting
1
TTI-621
1
Sunitinib
1
Razoxane
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiation
1
Polymerase Chain Reaction
1
Observation
1
Neoadjuvant Therapy
1
MLN 8237
1
Imatinib Mesylate
1
HhAntag691
1
Gene Expression Profiling
1
Dexrazoxane
1
Blotting, Western
1
Albumin-Bound Paclitaxel
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Dermatofibrosarcoma
×
Glutamine
×
Clear all
No trials found.